|
GB1555654A
(en)
*
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
DE2834122A1
(de)
*
|
1978-08-03 |
1980-02-14 |
Bayer Ag |
Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
|
|
DE2839309A1
(de)
*
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
|
DE2853573A1
(de)
*
|
1978-12-12 |
1980-07-03 |
Bayer Ag |
Herstellung von n-substituierten derivaten des l-desoxynojirimycins
|
|
DE3038901A1
(de)
*
|
1980-10-15 |
1982-05-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
|
|
DE3611841A1
(de)
*
|
1986-04-09 |
1987-10-15 |
Bayer Ag |
Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
|
|
US5103008A
(en)
*
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
|
US5043273A
(en)
*
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
|
US4994572A
(en)
*
|
1989-10-12 |
1991-02-19 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5030638A
(en)
*
|
1990-02-26 |
1991-07-09 |
G. D. Searle & Co. |
Method of antiviral enhancement
|
|
US5200523A
(en)
*
|
1990-10-10 |
1993-04-06 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5206251A
(en)
*
|
1992-04-01 |
1993-04-27 |
G. D. Searle & Co. |
2- and 3- amino and azido derivatives of 1,5-iminosugars
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
AU1876095A
(en)
*
|
1994-02-25 |
1995-09-11 |
G.D. Searle & Co. |
Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
|
|
KR20010033028A
(ko)
*
|
1997-12-11 |
2001-04-25 |
더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 |
막-관련 바이러스 복제의 억제
|
|
US6689759B1
(en)
*
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
|
US6610703B1
(en)
*
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB9828474D0
(en)
*
|
1998-12-24 |
1999-02-17 |
British Aerospace |
Surface topology inspection
|
|
ATE402701T1
(de)
*
|
1999-02-12 |
2008-08-15 |
United Therapeutics Corp |
N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
|
|
GB0100889D0
(en)
*
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
EP1196190B1
(en)
*
|
1999-07-26 |
2003-03-19 |
G.D. SEARLE & CO. |
Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
|
|
US7256005B2
(en)
*
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
US6565487B1
(en)
*
|
2000-07-17 |
2003-05-20 |
Hai Pin Kuo |
Exerciser having a forward and rearward adjusting seat
|
|
EP2857036B1
(en)
*
|
2003-01-31 |
2016-12-21 |
Mount Sinai School of Medicine of New York University |
Combination therapy for treating protein deficiency disorders
|
|
US7446098B2
(en)
*
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
|
US20060211752A1
(en)
*
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
US20050256168A1
(en)
*
|
2004-04-28 |
2005-11-17 |
Block Timothy M |
Compositions for oral administration for the treatment of interferon-responsive disorders
|
|
US7524829B2
(en)
*
|
2004-11-01 |
2009-04-28 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
|
GB0501352D0
(en)
*
|
2005-01-21 |
2005-03-02 |
Slingsby Jason H |
Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
|
|
CA2601797A1
(en)
*
|
2005-03-16 |
2006-09-21 |
University Of Oxford |
Mannose immunogens for hiv-1
|
|
CN101355971A
(zh)
*
|
2005-05-17 |
2009-01-28 |
阿米库斯治疗学公司 |
使用1-去氧野尻霉素衍生物治疗庞皮病的方法
|
|
EP3782655A1
(en)
*
|
2005-05-17 |
2021-02-24 |
Amicus Therapeutics, Inc. |
A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
|
|
KR20080031474A
(ko)
*
|
2005-07-27 |
2008-04-08 |
유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. |
안구 질환의 치료를 위한 열충격의 사용
|
|
US20100004156A1
(en)
*
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
US20070244184A1
(en)
*
|
2006-01-09 |
2007-10-18 |
Simon Fraser University |
Glycosidase inhibitors and methods of synthesizing same
|
|
DE602007008870D1
(de)
*
|
2006-04-24 |
2010-10-14 |
Amc Amsterdam |
Verbessertes verfahren zur behandlung von cystischer fibrose
|
|
CN104876855A
(zh)
*
|
2006-05-24 |
2015-09-02 |
联合治疗公司 |
脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
|
|
JP2009545621A
(ja)
*
|
2006-08-02 |
2009-12-24 |
ユナイテッド セラピューティクス コーポレーション |
ウィルス感染症のリポソーム処置
|
|
KR20090057035A
(ko)
*
|
2006-08-21 |
2009-06-03 |
유나이티드 세러퓨틱스 코오포레이션 |
바이러스 감염의 치료를 위한 병용 요법
|
|
KR20100127842A
(ko)
*
|
2008-03-26 |
2010-12-06 |
유니버시티 오브 옥스퍼드 |
소포체 표적화 리포좀
|
|
WO2010027996A1
(en)
*
|
2008-09-02 |
2010-03-11 |
Institute For Hepatitis And Virus Research |
Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|